Prostatis Group’s Pacer Trendpilot US Bond ETF PTBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-49,555
Closed -$49.6K 193
2023
Q2
$49.6K Buy
+49,555
New +$992K 0.02% 179
2022
Q2
Sell
-93,211
Closed -$2.27M 72
2022
Q1
$2.27M Buy
93,211
+4,050
+5% +$104K 1.82% 21
2021
Q4
$2.4M Sell
89,161
-46,027
-34% -$1.24M 1.47% 23
2021
Q3
$3.67M Buy
135,188
+13,006
+11% +$360K 2.19% 13
2021
Q2
$3.39M Buy
122,182
+8,749
+8% +$241K 2.31% 12
2021
Q1
$3.09M Buy
+113,433
New +$3.11M 2.43% 11

Other funds holding PTBD

Prostatis Group's PTBD Position: Q3 2023 in Review

Prostatis Group sold out of Pacer Trendpilot US Bond ETF (PTBD) in Q3 2023, closing a stake of 49,555 shares — an estimated $49.6K sold.

Prostatis Group first reported a position in PTBD in Q1 2021 and held it in 6 quarters. The position peaked at $3.67M in Q3 2021. 60 funds tracked by Wall St. Rank hold PTBD as of Q3 2023.

  • Prostatis Group reported no remaining Pacer Trendpilot US Bond ETF position as of Q3 2023 after selling out during the quarter.
  • Prostatis Group sold 49,555 Pacer Trendpilot US Bond ETF shares in Q3 2023, an estimated $49.6K.
  • Prostatis Group first reported a position in Pacer Trendpilot US Bond ETF in Q1 2021 and held it in 6 quarters.
  • Prostatis Group's Pacer Trendpilot US Bond ETF position peaked at $3.67M in Q3 2021.
  • 60 funds tracked by Wall St. Rank held Pacer Trendpilot US Bond ETF as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.